Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Physiologic basis for hormonal theapy in carcinoma of the prostate.

× No keyword cloud information.

17 in total

Review 1. [Problems and principles of hormone therapy of advanced prostate cancer].

Authors: J E Altwein; P Faul
Journal: Klin Wochenschr Date: 1990-04-02

2. Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.

Authors: M Landström; J E Damber; A Bergh; R Tomic
Journal: J Cancer Res Clin Oncol Date: 1992 Impact factor: 4.553

3. Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer.

Authors: Rutger J Dost; Andor W J M Glaudemans; Anthonius J Breeuwsma; Igle J de Jong
Journal: Eur J Nucl Med Mol Imaging Date: 2013-04-06 Impact factor: 9.236

4. Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a nested case-control study in UK primary care.

Authors: Elisa Martín-Merino; Saga Johansson; Thomas Morris; Luis A García Rodríguez
Journal: Drug Saf Date: 2011-11-01 Impact factor: 5.606

5. Is the detection rate of 18F-choline PET/CT influenced by androgen-deprivation therapy?

Authors: Sotirios Chondrogiannis; Maria Cristina Marzola; Alice Ferretti; Gaia Grassetto; Anna Margherita Maffione; Lucia Rampin; Stefano Fanti; Francesco Giammarile; Domenico Rubello
Journal: Eur J Nucl Med Mol Imaging Date: 2014-02-25 Impact factor: 9.236

Review 6. Update in cancer chemotherapy: genitourinary tract cancer, Part 3: Cancer of the prostate.

Authors: J C Wright
Journal: J Natl Med Assoc Date: 1988-03 Impact factor: 1.798

7. Endocrine treatment of prostatic cancer.

Authors: G Williams
Journal: J R Soc Med Date: 1985-10 Impact factor: 5.344

8. Circulating testosterone, prostatic nuclear androgen receptor and time to progression in patients with metastatic disease of the prostate treated by orchiectomy.

Authors: O G van Aubel; J Bolt-de Vries; M A Blankenstein; F H de Jong; F H Schröder
Journal: Urol Res Date: 1989

9. Prostatic carcinoma metastatic to choroid.

Authors: J P Dieckert; B B Berger
Journal: Br J Ophthalmol Date: 1982-04 Impact factor: 4.638

10. The influence of bilateral orchiectomy on volume changes of the prostate in men with advanced prostatic cancer--the predictive value.

Authors: R Zdrojowy
Journal: Int Urol Nephrol Date: 1992 Impact factor: 2.370